This site is intended for healthcare professionals only
LoginRegister
Medtonic to invest nearly Rs 430 crore in new diabetes GCC in PuneMedtronic to spin off diabetes business
Cipla, Hetero win bid to supply widely prescribed diabetes drug in ChinaNeurotrophin peptidomimetic drugs offer promise for treating neurodegenerative disorders, finds...
Bayer new drug application for gadoquatrane accepted for review in ChinaBayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with hemophilia A
Phase III data for Gazyva/Gazyvaro show significant reduction in disease activity for systemic lupus erythematosus: RocheUSFDA Advisory Committee reviews Roche Columvi Combo for diffuse large B-cell Lymphoma
Biocon Biologics Gets Health Canada Nod for Yesintek, a Biosimilar to StelaraBiocon Biologics commercial partner launches psoriatic arthritis injection in Japan
Bharat Biotech Oral Cholera vaccine Hillchol​ shows success in Phase III clinical studiesBharat Biotech Oral Cholera vaccine Hillcholl shows success in Phase III studies
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug SoaanzUSFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug Soaanz
ZydusZydus Lifesciences gets CDSCO Panel nod to study Aprepitant powder for Oral Suspension
AstraZeneca Pharma India Slapped Rs 11.88 Cr Tax Adjustment for FY23, to Move ITATAstraZeneca Pharma India gets CDSCO Panel nod for Anti-cancer Drug Osimertinib Tablets 40 mg and 80...
Cipla Names Arun Kakatkar as Global Chief People OfficerCipla arm to acquire 26% stake in AMPIN Energy C&I Eighteen
Lupin secures SBTi validation for emission reduction targetsLupin collaborate with Honeywell for usage of propellant for inhalers
Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitisJanssen-Cilag Guselkumab receives UK nod for Crohn's disease, ulcerative colitis
X